CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 84 filers reported holding CYTOKINETICS INC in Q4 2014. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,957,000 | +84.8% | 409,679 | +96.2% | 0.36% | +93.0% |
| Q1 2017 | $2,682,000 | -32.1% | 208,781 | -44.7% | 0.19% | -34.2% |
| Q4 2015 | $3,951,000 | +173.0% | 377,801 | +74.6% | 0.28% | +175.7% |
| Q3 2015 | $1,447,000 | +86.7% | 216,368 | +87.5% | 0.10% | +77.6% |
| Q2 2015 | $775,000 | +258.8% | 115,379 | +261.1% | 0.06% | +286.7% |
| Q1 2015 | $216,000 | -80.8% | 31,949 | -90.0% | 0.02% | -79.5% |
| Q3 2014 | $1,125,000 | -57.4% | 319,647 | -42.2% | 0.07% | -58.8% |
| Q2 2014 | $2,643,000 | -21.4% | 553,008 | +56.1% | 0.18% | -23.4% |
| Q1 2014 | $3,364,000 | -0.6% | 354,180 | -20.8% | 0.23% | -32.7% |
| Q3 2013 | $3,384,000 | – | 447,035 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |